{"id":"arxiv:2110.12723","kind":"article","title":"Rapid and Accurate Detection of SARS-CoV-2 Mutations using a Cas12a-based Sensing Platform","authors":["C He","C Lin","G Mo","B Xi","A Li","D Huang","Y Wan","F Chen","Y Liang","Q Zuo","W Xu","D Feng","G Zhang","L Han","C Ke","H Du","L Huang"],"author_count":17,"year":2021,"published":"2021-10-25","venue":"Biosensors and Bioelectronics","cited_by":62,"doi":"10.1016/j.bios.2021.113857","arxiv_id":"2110.12723","nct_id":null,"source_url":"https://arxiv.org/abs/2110.12723","archive_url":"https://space-kitty.com/papers/arxiv:2110.12723","updated":"2021-10-25","pmid":null,"pmcid":null,"openalex_id":"W3216794941","pdf_url":"https://arxiv.org/pdf/2110.12723","abstract":"The increasing prevalence of SARS-CoV-2 variants with spike mutations has raised concerns owing to higher transmission rates, disease severity, and escape from neutralizing antibodies. Rapid and accurate detection of SARS-CoV-2 variants provides crucial information concerning the outbreaks of SARS-CoV-2 variants and possible lines of transmission. This information is vital for infection prevention and control. We used a Cas12a-based RT-PCR combined with CRISPR on-site rapid detection system (RT-CORDS) platform to detect the key mutations in SARS-COV-2 variants, such as 69/70 deletion, N501Y, and D614G. We used type-specific CRISPR RNAs (crRNAs) to identify wild-type (crRNA-W) and mutant (crRNA-M) sequences of SARS-CoV-2. We successfully differentiated mutant variants from wild-type SARS-CoV-2 with a sensitivity of $10^{-17}$ M (approximately 6 copies/$μ$L). The assay took just 10 min with the Cas12a/crRNA reaction after a simple RT-PCR using a fluorescence reporting system. In addition, a sensitivity of $10^{-16}$ M could be achieved when lateral flow strips were used as readouts. The accuracy of RT-CORDS for SARS-CoV-2 variant detection was 100% consistent with the sequencing data. In conclusion, using the RT-CORDS platform, we accurately, sensitively, specifically, and rapidly detected SARS-CoV-2 variants. This method may be used in clinical diagnosis.","abstract_license":"CC0-1.0 (arXiv descriptive metadata)","license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["q-bio.QM","q-bio.BM"],"details":null,"provenance":"arxiv","attribution":"Abstract: arXiv descriptive metadata (CC0). Thank you to arXiv for use of its open access interoperability. This service was not reviewed or approved by, nor does it necessarily express or reflect the policies or opinions of, arXiv.","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}